Glycolysis Learning Objectives
Comprehensive Overview Based on the Slides
1. Discuss the Hormonal Regulation of Carbohydrate Metabolism
- Insulin: Released during the fed state, insulin promotes the storage of fuels and the synthesis of complex molecules. It activates enzymes via dephosphorylation, facilitating glucose uptake into cells (especially muscle and fat cells via GLUT4) and promoting glycogen synthesis in the liver.
- Glucagon: Released during the fasting state, glucagon maintains blood glucose levels by increasing glucose secretion from the liver. It activates enzymes via phosphorylation, promoting glycogenolysis and gluconeogenesis.
- Stress Hormones (Epinephrine and Cortisol):
- Epinephrine: Short-term stress hormone that increases fuel availability in the blood by stimulating glycogenolysis in the liver and muscles.
- Cortisol: Long-term stress hormone that promotes gluconeogenesis and protein breakdown to provide glucose.
2. Compare and Contrast the Actions of Insulin and Glucagon
- Insulin:
- Fed State: Promotes glucose uptake, glycogen synthesis, and fat storage.
- Mechanism: Activates enzymes via dephosphorylation, increases GLUT4 translocation to the cell membrane in muscle and fat cells.
- Target Tissues: Liver, muscle, and adipose tissue.
- Glucagon:
- Fasting State: Promotes glycogenolysis and gluconeogenesis to maintain blood glucose levels.
- Mechanism: Activates enzymes via phosphorylation, increases glucose production in the liver.
- Target Tissue: Primarily the liver.
3. Describe the Role of Different Glucose Transporters – Compare GLUT2 and GLUT4
- GLUT2:
- Location: Liver, intestinal cells, and pancreatic β-cells.
- Function: Transports glucose, galactose, and fructose. In the liver, it removes excess glucose from the blood. In pancreatic β-cells, it plays a role in insulin regulation.
- Kinetics: High Km (15-20 mM), meaning it functions best at high glucose concentrations.
- Insulin Sensitivity: Not responsive to insulin.
- GLUT4:
- Location: Muscle and fat cells.
- Function: Mediates insulin-stimulated glucose uptake. The amount of GLUT4 in the plasma membrane increases with endurance training.
- Kinetics: Lower Km (5 mM), meaning it functions at lower glucose concentrations.
- Insulin Sensitivity: Highly responsive to insulin, which stimulates its translocation to the cell membrane.
4. Describe Regulatory (Irreversible Reaction) Enzymes of Glycolysis
- Hexokinase vs. Glucokinase:
- Hexokinase:
- Location: All tissues.
- Kinetics: Low Km (high affinity for glucose), works at maximum rate even at low blood glucose levels.
- Regulation: Inhibited by its product, glucose-6-phosphate (feedback inhibition).
- Glucokinase:
- Location: Liver and pancreatic β-cells.
- Kinetics: High Km (low affinity for glucose), functions best at high glucose concentrations.
- Regulation: Induced by insulin, no feedback inhibition.
- Phosphofructokinase-1 (PFK-1):
- Role: Catalyzes the first committed step of glycolysis, converting fructose-6-phosphate to fructose-1,6-bisphosphate.
- Regulation: Allosterically regulated by ATP (inhibitor), AMP (activator), and citrate (inhibitor). Fructose-2,6-bisphosphate (F2,6BP) is a potent activator of PFK-1.
- Hormonal Regulation: Insulin activates PFK-1 via F2,6BP, while glucagon inhibits it.
- Pyruvate Kinase (PK):
- Role: Catalyzes the final step of glycolysis, converting phosphoenolpyruvate (PEP) to pyruvate, producing ATP.
- Regulation: Allosterically activated by fructose-1,6-bisphosphate (feed-forward activation) and inhibited by ATP. Hormonally regulated by insulin (activation) and glucagon (inhibition via phosphorylation).
5. Describe the Differences in Regulation of Glycolysis in Liver and Muscle
- Liver:
- Fed State: Insulin activates glycolysis by increasing GLUT2 activity, glucokinase, and PFK-1 (via F2,6BP).
- Fasting State: Glucagon inhibits glycolysis by decreasing F2,6BP levels, thus inhibiting PFK-1 and pyruvate kinase.
- Muscle:
- Fed State: Insulin stimulates glucose uptake via GLUT4 and activates glycolysis.
- Exercise: AMP and F2,6BP activate PFK-1, increasing glycolysis to meet energy demands.
- Rest: ATP and citrate inhibit PFK-1, reducing glycolysis when energy is sufficient.
6. Discuss How Citrate Inhibits Glycolysis in Muscle but Not in Liver
- Citrate:
- Muscle: Citrate, a product of the citric acid cycle, inhibits PFK-1, signaling that there is sufficient energy (ATP) and substrates for the cycle, thus slowing glycolysis.
- Liver: Citrate does not significantly inhibit PFK-1 in the liver because the liver’s primary role is to maintain blood glucose levels, not to produce ATP for immediate energy needs.
7. Discuss How Epinephrine Activates Glycolysis in Muscle but Not in Liver
- Epinephrine:
- Muscle: Epinephrine activates glycolysis by stimulating glycogenolysis, providing glucose-6-phosphate for glycolysis. It also increases AMP levels, which activate PFK-1.
- Liver: Epinephrine primarily stimulates glycogenolysis to release glucose into the bloodstream rather than activating glycolysis.
8. Compare Aerobic and Anaerobic Glycolysis
- Aerobic Glycolysis:
- End Product: Pyruvate is converted to acetyl-CoA, which enters the citric acid cycle, producing a large amount of ATP (up to 38 ATP per glucose).
- Oxygen Requirement: Requires oxygen.
- Efficiency: Highly efficient in terms of ATP production.
- Anaerobic Glycolysis:
- End Product: Pyruvate is converted to lactate (in muscles) or ethanol (in yeast), regenerating NAD+ for continued glycolysis.
- Oxygen Requirement: Does not require oxygen.
- Efficiency: Less efficient, producing only 2 ATP per glucose.
9. List the Energy Gains and Expenditures of Aerobic and Anaerobic Glycolysis
- Aerobic Glycolysis:
- ATP Gain: Up to 38 ATP per glucose molecule.
- Expenditure: Requires oxygen and the functioning of the citric acid cycle and oxidative phosphorylation.
- Anaerobic Glycolysis:
- ATP Gain: 2 ATP per glucose molecule.
- Expenditure: Does not require oxygen but produces lactate, which can lead to muscle fatigue.
10. Discuss the Biochemical Basis of Important Pathological Deficiencies of Glycolysis
- PFK-1 Deficiency (Tarui Disease):
- Symptoms: Exercise intolerance, muscle cramps, and hemolysis due to impaired glycolysis in muscles and red blood cells.
- Biochemical Basis: Lack of PFK-1 activity leads to accumulation of fructose-6-phosphate and decreased ATP production in muscles.
- GLUT-1 Deficiency:
- Symptoms: Seizures, developmental delay, and low cerebrospinal fluid glucose levels.
- Biochemical Basis: Impaired glucose transport into the brain due to defective GLUT1 transporters.
- Glucokinase Deficiency:
- Symptoms: Maturity-onset diabetes of the young (MODY), characterized by impaired insulin secretion and hyperglycemia.
- Biochemical Basis: Reduced glucokinase activity in pancreatic β-cells leads to decreased glucose sensing and insulin release.
- Pyruvate Kinase Deficiency:
- Symptoms: Hemolytic anemia due to reduced ATP production in red blood cells.
- Biochemical Basis: Lack of pyruvate kinase activity leads to accumulation of phosphoenolpyruvate and decreased ATP production, causing red blood cell lysis.
Summary
- Hormonal Regulation: Insulin promotes glucose storage and utilization, while glucagon promotes glucose production during fasting.
- GLUT2 vs. GLUT4: GLUT2 is liver-specific and insulin-independent, while GLUT4 is muscle/fat-specific and insulin-dependent.
- Regulatory Enzymes: Hexokinase, PFK-1, and pyruvate kinase are key regulatory points in glycolysis, each with distinct roles and regulation mechanisms.
- Liver vs. Muscle: Glycolysis in the liver is regulated by blood glucose levels, while in muscle, it is regulated by energy demand.
- Aerobic vs. Anaerobic: Aerobic glycolysis is more efficient but requires oxygen, while anaerobic glycolysis is less efficient but can function without oxygen.
- Pathological Deficiencies: Deficiencies in key glycolytic enzymes (PFK-1, GLUT1, glucokinase, pyruvate kinase) lead to various metabolic disorders, each with distinct symptoms and biochemical consequences.